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Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES, MIM 110100) is an 
autosomal dominant genetic condition in which an eyelid malformation is associated (type I) 
or not (type II) with premature ovarian failure (POF). In 2001, mutations in the FOXL2 gene, 
encoding a forkhead transcription factor, have been shown to cause BPES type I and II. Since 
then a number of publications appeared describing FOXL2 mutations in BPES patients. In 
addition, there have been reported a few FOXL2 variants in POF patients and XX males.  
Previously, our group has reported the existence of two mutational hotspots in FOXL2 and of 
intra- and interfamilial phenotypic variability in BPES families. Moreover, we have 
demonstrated genotype-phenotype correlations for a number of mutations in BPES patients.  
Here we describe a new locus-specific Human FOXL2 Allelic Variant Database 
(http://allserv.ugent.be/~jvdesomp/foxl2/), created using the MuStaR software (on which the 
PAX6, PAX2, SHOX and MLYCD Allelic Variant Databases have been based similarly). Our 
database contains general information about the FOXL2 gene, as well as details about more 
than 125 intragenic mutations and variants of FOXL2, obtained from published papers and 
abstracts of meetings, and also from unpublished data of our group. Not included in the 
current version of the database are complete FOXL2 deletions, microdeletions and cytogenetic 
rearrangements of the FOXL2 region on 3q23.  
The aim of this database is to provide an online resource, allowing remote users to do queries 
by selecting options on a web form and to submit new mutations to the database by means of 
a submission form. We believe this database will be very useful as it contains prevalence data 
about disease-causing mutations, a catalogue of polymorphisms and as it will facilitate more 
accurate genotype-phenotype correlations to be made.  
 
